ClinicalTrials.gg
Drug

Finerenone clinical trials

Also written Kerendia and BAY94-8862.

studies test it
75
open now
43
in phase 3
20
first study started
2010

How each study uses finerenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the finerenone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Jul 2021 · KERENDIA · NDA 215341 (FDA, Drugs@FDA)
European Union
16 Feb 2022 · Kerendia · EMEA/H/C/005200 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Finerenone
34
Finerenone (BAY94-8862)
9
Finerenone (Kerendia, BAY94-8862)
6
Finerenone (BAY 94-8862)
5
Finerenone Oral Tablet
4

Brand

Kerendia
11

Development codes

BAY94-8862
5

Studies by the year they started

74 studies that test it; most in 2026 (22); 1 more planned to start later

Studies that test finerenone, by start year
YearStudies
20102
20111
20121
20134
20141
20152
20162
20201
20213
20223
20236
202415
202511
202622

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
15
Phase 3
20
Phase 4
25
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 50

Bayer (25) · University Medical Center Groningen (3) · Colorado Prevention Center (3) · Chongqing Medical University (2) · Alexandria University (2) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · Steno Diabetes Center Copenhagen (2) · Peter Rossing (2)

Often tested with

Tested in the same studies.

Empagliflozin (6) · Semaglutide (5) · Dapagliflozin (4) · Sotagliflozin (3) · Benazepril (1) · Captopril (1) · Enalapril (1) · Fosinopril (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 16, 4 in phase 3

Studies that test finerenone, phase 3 first.

Studies

Open first, then newest update. How each study uses finerenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test finerenone →

Given beside what is tested · 2 — finerenone is usual care or a partner of the new treatment

Codes

What other systems call finerenone · ClinicalTrials.gg INT006186

  • MeSH (NLM) C576501finerenoneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) DE2O63YV8RFINERENONEConfirmed FDA, NLM, Wikidata
  • RxNorm 2562811One source FDA
  • Wikidata Q21099046finerenoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169981FinerenoneOne source FDA
  • DrugBank DB16165One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.